It was a brave thing for the Food and Drug Administration to do. Earlier this week, the agency put one of its regulatory officers in front of a room full of scientists clamoring for answers on how the agency intends to regulate artificial intelligence in medicine.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
